Johns Hopkins Medicine researchers identified a significant link between a common gum disease bacterium and breast cancer progression. Published on March 19, 2026, the study suggests the microbe may fuel tumor growth in patients with specific genetic profiles. This discovery connects oral health directly to critical oncology outcomes for millions of women globally for healthcare systems.
The study focuses on Fusobacterium nucleatum, a microbe previously associated with colorectal cancer and other systemic malignancies. Scientists found the organism travels through the bloodstream and settles in breast tissue where it triggers inflammation. This migration causes early cellular changes linked to malignancy and accelerates the spread of existing tumors significantly.
Experiments using mouse models revealed that the bacterium accelerates tumor growth and promotes metastasis to the lungs significantly. When introduced into breast ducts, it caused metaplastic lesions characterized by excessive cell growth and structural shifts. These noncancerous changes were accompanied by severe DNA damage and increased cell proliferation rates within the tissue over time.
Exposure to the pathogen damaged cellular DNA and activated repair systems prone to errors during the healing process. One specific mechanism, nonhomologous end joining, reconnects broken strands but introduces mutations that drive aggression. Even short exposure increased levels of a protein called PKcs associated with greater chemotherapy resistance and invasion.
Epithelial cells carrying BRCA1 mutations appeared especially susceptible to the infection compared to healthy tissue samples. These cells possessed elevated levels of a surface sugar which helps bacteria attach and enter the cellular structure. As a result, these cells absorbed more bacteria and retained it across multiple generations intensifying DNA damage and cancer-promoting effects.
Dipali Sharma, a senior researcher at the Bloomberg~Kimmel Institute, stated the findings reveal a link between oral microbes and breast cancer risk. She noted that nothing happens in isolation regarding these complex biological risk factors and environmental triggers. The results suggest F. nucleatum acts as an environmental factor cooperating with inherited mutations to promote cancer and tumor aggressiveness.
Prior research connected periodontal disease to breast cancer through large patient studies across various demographics. This new work investigates deeper to uncover underlying biological connections using controlled animal models and human cells. The research team included Sheetal Parida and other associates from the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute.
Researchers emphasize that more work is needed to understand how findings translate to practical patient care protocols. Future studies will explore whether maintaining good oral health reduces breast cancer risk or improves treatment outcomes. The study received support from the Breast Cancer Research Foundation and Department of Defense grants for cancer prevention and treatment programs.
